The NATO Innovation Fund has made its first investment in biotechnology, co-funding $35 million for Portal Biotech, a British company specializing in biothreat detection through protein sequencing. This technology, backed by artificial intelligence, is essential for biosecurity, enabling continuous monitoring of pathogens in diverse environments. The fund, created in 2022, aims to invest more than $1 billion in technologies to strengthen NATO's defenses.
Sources
NATO se implică financiar într-o companie de biotehnologie, pentru a contacara amenințările biologice - Economica.net
Premieră - NATO se implică financiar într-o companie de biotehnologie
Premieră - NATO se implică financiar într-o companie de biotehnologie
NATO se implică financiar într-o companie de biotehnologie pentru a contracara amenințările biologice
NATO se implică financiar într-o companie de biotehnologie pentru a contracara ameninţările biologice
Latest News
07:45
Céline Dion returned to the stage in Paris, where she gave her first major live concert in six years
07:31
Musk, Altman, and Amodei call for slowing AI development, citing risks that could become impossible to control
07:18
Nicuşor Dan participates in Finland at the summit dedicated to the security and development of the Arctic region
07:04
Sever Voinescu: Politeness and the Decline of Intelligence
23:13
The Hungarian government will offer owners of eligible diesel cars 5,000 forints per month until the end of the year
See more news